1067 related articles for article (PubMed ID: 25447847)
1. Gut-liver axis in alcoholic liver disease.
Szabo G
Gastroenterology; 2015 Jan; 148(1):30-6. PubMed ID: 25447847
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor-mediated signaling cascade as a regulator of the inflammation network during alcoholic liver disease.
Ceccarelli S; Nobili V; Alisi A
World J Gastroenterol; 2014 Nov; 20(44):16443-51. PubMed ID: 25469012
[TBL] [Abstract][Full Text] [Related]
3. Alcoholic liver disease: the gut microbiome and liver cross talk.
Hartmann P; Seebauer CT; Schnabl B
Alcohol Clin Exp Res; 2015 May; 39(5):763-75. PubMed ID: 25872593
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiota in alcoholic liver disease: pathogenetic role and therapeutic perspectives.
Malaguarnera G; Giordano M; Nunnari G; Bertino G; Malaguarnera M
World J Gastroenterol; 2014 Nov; 20(44):16639-48. PubMed ID: 25469033
[TBL] [Abstract][Full Text] [Related]
5. Microbiota-based treatments in alcoholic liver disease.
Sung H; Kim SW; Hong M; Suk KT
World J Gastroenterol; 2016 Aug; 22(29):6673-82. PubMed ID: 27547010
[TBL] [Abstract][Full Text] [Related]
6. Alcohol or Gut Microbiota: Who Is the Guilty?
Meroni M; Longo M; Dongiovanni P
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540133
[TBL] [Abstract][Full Text] [Related]
7. Gut Microbiota and Alcoholic Liver Disease.
Scarpellini E; Forlino M; Lupo M; Rasetti C; Fava G; Abenavoli L; De Santis A
Rev Recent Clin Trials; 2016; 11(3):213-9. PubMed ID: 27515958
[TBL] [Abstract][Full Text] [Related]
8. Immunoglobulin A and liver diseases.
Inamine T; Schnabl B
J Gastroenterol; 2018 Jun; 53(6):691-700. PubMed ID: 29075899
[TBL] [Abstract][Full Text] [Related]
9. Are Probiotics Effective in Targeting Alcoholic Liver Diseases?
Hong M; Han DH; Hong J; Kim DJ; Suk KT
Probiotics Antimicrob Proteins; 2019 Jun; 11(2):335-347. PubMed ID: 29687200
[TBL] [Abstract][Full Text] [Related]
10. Intestinal HIF-1α deletion exacerbates alcoholic liver disease by inducing intestinal dysbiosis and barrier dysfunction.
Shao T; Zhao C; Li F; Gu Z; Liu L; Zhang L; Wang Y; He L; Liu Y; Liu Q; Chen Y; Donde H; Wang R; Jala VR; Barve S; Chen SY; Zhang X; Chen Y; McClain CJ; Feng W
J Hepatol; 2018 Oct; 69(4):886-895. PubMed ID: 29803899
[TBL] [Abstract][Full Text] [Related]
11. Circadian rhythms, alcohol and gut interactions.
Forsyth CB; Voigt RM; Burgess HJ; Swanson GR; Keshavarzian A
Alcohol; 2015 Jun; 49(4):389-98. PubMed ID: 25499101
[TBL] [Abstract][Full Text] [Related]
12. Bacterial translocation in patients with liver cirrhosis: physiology, clinical consequences, and practical implications.
Ponziani FR; Zocco MA; Cerrito L; Gasbarrini A; Pompili M
Expert Rev Gastroenterol Hepatol; 2018 Jul; 12(7):641-656. PubMed ID: 29806487
[TBL] [Abstract][Full Text] [Related]
13.
Li H; Shi J; Zhao L; Guan J; Liu F; Huo G; Li B
J Agric Food Chem; 2021 Jan; 69(1):183-197. PubMed ID: 33353302
[TBL] [Abstract][Full Text] [Related]
14. Inulin Ameliorates Alcoholic Liver Disease via Suppressing LPS-TLR4-Mψ Axis and Modulating Gut Microbiota in Mice.
Yang X; He F; Zhang Y; Xue J; Li K; Zhang X; Zhu L; Wang Z; Wang H; Yang S
Alcohol Clin Exp Res; 2019 Mar; 43(3):411-424. PubMed ID: 30589437
[TBL] [Abstract][Full Text] [Related]
15. The intestinal microbiota as a therapeutic target in the treatment of NAFLD and ALD.
Huang W; Kong D
Biomed Pharmacother; 2021 Mar; 135():111235. PubMed ID: 33561650
[TBL] [Abstract][Full Text] [Related]
16. Alcoholic liver disease: focus on prodromal gut health.
Park B; Lee HR; Lee YJ
J Dig Dis; 2016 Aug; 17(8):493-500. PubMed ID: 27356233
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiota and liver diseases.
Minemura M; Shimizu Y
World J Gastroenterol; 2015 Feb; 21(6):1691-702. PubMed ID: 25684933
[TBL] [Abstract][Full Text] [Related]
18. Role of Microbiota-Derived Metabolites in Alcoholic and Non-Alcoholic Fatty Liver Diseases.
Park JW; Kim SE; Lee NY; Kim JH; Jung JH; Jang MK; Park SH; Lee MS; Kim DJ; Kim HS; Suk KT
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008852
[TBL] [Abstract][Full Text] [Related]
19. The gut-liver axis in liver disease: Pathophysiological basis for therapy.
Albillos A; de Gottardi A; Rescigno M
J Hepatol; 2020 Mar; 72(3):558-577. PubMed ID: 31622696
[TBL] [Abstract][Full Text] [Related]
20. Intestinal dysbiosis and permeability: the yin and yang in alcohol dependence and alcoholic liver disease.
Stärkel P; Leclercq S; de Timary P; Schnabl B
Clin Sci (Lond); 2018 Jan; 132(2):199-212. PubMed ID: 29352076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
